The study estimated deaths attributable to fine particulate matter (PM2.5) in mainland China from 2013 to 2024. It combined 1 km exposure and population grids with Global Burden of Disease 2023 risk curves for seven diseases. In 2024, full compliance with 25 μg m-3 would cut attributable deaths by 16.1%, against 3.7% at 35 μg m-3. PM2.5-specific progress towards the WHO 2040 halving target would reach 83.4%, against 66.2% at 35 μg m-3. Deaths would fall 22.8% for chronic obstructive pulmonary disease, but 1.4% for dementia and 1.1% for type 2 diabetes. The scenarios assume idealised full compliance, and the uncertainty intervals leave out error in exposure and population.
Why it is interesting: The modelled gains fall mainly on stroke, ischaemic heart disease and lung disease, not on dementia or diabetes. Attributable new dementia cases rose 60.6% from 2013 despite cleaner air, which the authors link partly to ageing.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.